Overview
Insurance provider's Q4 revenue missed analyst expectations
Adjusted EPS for Q4 beat analyst expectations
Company reported strong volume growth and improved expense margins
Outlook
MetLife did not provide specific future guidance in the press release
Result Drivers
PREMIUM GROWTH - Record sales in pension risk transfers and U.K. longevity reinsurance drove a 29% increase in premiums, fees, and other revenues
INVESTMENT INCOME - Higher variable investment income, particularly from private equity, contributed to a 10% rise in net investment income
EXPENSE MANAGEMENT - Improved expense margins supported a 13% increase in adjusted earnings
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q4 Revenue | Miss | $23.81 bln | $27.73 bln (7 Analysts) |
Q4 Adjusted EPS | Beat | $2.49 | $2.34 (15 Analysts) |
Q4 EPS | $1.17 | ||
Q4 Adjusted Net Income | $1.65 bln | ||
Q4 Net Income | $778 mln |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy", 5 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the life & health insurance peer group is "buy"
Wall Street's median 12-month price target for MetLife Inc is $93.50, about 21.6% above its February 3 closing price of $76.90
The stock recently traded at 8 times the next 12-month earnings vs. a P/E of 8 three months ago
Press Release: ID:nBw9ZB55Fa
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)